$69.00
1.46%
Nasdaq, Sep 30, 04:01 pm EDT. Closed.
ISIN
US74265M2052
Symbol
PDEX

Pro-Dex, Inc. Stock price

$70.02
+7.92 12.75% 1M
+22.58 47.60% 6M
+31.54 81.96% YTD
+36.12 106.55% 1Y
+54.32 345.99% 3Y
+44.46 173.94% 5Y
+65.61 1,487.76% 10Y
+66.00 1,641.79% 20Y
Nasdaq, Closing price Tue, Sep 29 2026
-1.60 2.23%

Is Pro-Dex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$224.3m
Enterprise Value
$232.4m
Net debt
$8.1m
Cash
$9.3m
Shares outstanding
3.2m
Valuation (TTM | estimate)
P/E
17.2
P/S
2.9 | 2.7
EV/Sales
3.0 | 2.8
EV/FCF
34.4
P/B
4.7
Financial Health
Equity Ratio
63.9%
Return on Equity
28.7%
ROCE
21.1%
ROIC
16.2%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$77.6m | $84.4m
EBITDA
$14.4m
EBIT
$13.0m
Net Income
$13.7m
Free Cash Flow
$6.8m
Growth (TTM | estimate)
Revenue
16.5% | 8.8%
EBITDA
20.6%
EBIT
21.6%
Net Income
52.1%
Free Cash Flow
330.7%
Margin
Gross
31.4%
EBITDA
18.6%
EBIT
16.8%
Net
17.6%
Free Cash Flow
8.7%
More
EPS
$4.1
FCF per Share
$2.1
Short interest
28.8%
Employees
180
Rev per Employee
$430.0k

Pro-Dex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Pro-Dex, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Pro-Dex, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Pro-Dex, Inc.

Jun '26
+/-
%
78 78
16% 16%
100%
- Direct Costs 53 53
13% 13%
69%
24 24
25% 25%
31%
- Selling and Administrative Expenses 8 8
54% 54%
10%
- Research and Development Expense 3.35 3.35
8% 8%
4%
14 14
21% 21%
19%
- Depreciation and Amortization 1.39 1.39
12% 12%
2%
EBIT (Operating Income) EBIT 13 13
22% 22%
17%
Net Profit 14 14
52% 52%
18%

In millions USD.

Don't miss a Thing! We will send you all news about Pro-Dex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pro-Dex, Inc. Stock News

Neutral
Accesswire
●
27 days ago
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Neutral
Accesswire
●
5 months ago
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.

Company Profile

Pro-Dex, Inc. engages in the design, development, and manufacture of rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. It specializes in medical device and services, industrial and scientific, dental and component, repairs, and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding, and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Head office United States
CEO Mr. Kirk
Employees 180
Founded 1994
Website www.pro-dex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today